Takeda-Led Covid Plasma Treatment Enters Clinical Trial With 1st Patient

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months...

https://ift.tt/eA8V8J